
Sean E. Aeder
Examiner (ID: 2139, Phone: (571)272-8787 , Office: P/1642 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1642 |
| Total Applications | 1939 |
| Issued Applications | 907 |
| Pending Applications | 201 |
| Abandoned Applications | 855 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10695026
[patent_doc_number] => 20160041173
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-11
[patent_title] => 'METHODS AND ARRAYS FOR USE IN THE SAME'
[patent_app_type] => utility
[patent_app_number] => 14/781839
[patent_app_country] => US
[patent_app_date] => 2014-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 19376
[patent_no_of_claims] => 112
[patent_no_of_ind_claims] => 75
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14781839
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/781839 | Methods and arrays for use in the same | Apr 1, 2014 | Issued |
Array
(
[id] => 9772434
[patent_doc_number] => 20140296097
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-02
[patent_title] => 'MARKER FOR DETERMING EFFECTS OF ANTI-C-MET ANTIBODY AND METHOD OF DETERMING EFFECTS OF ANTI-C-MET ANTIBODY USING THE MARKER'
[patent_app_type] => utility
[patent_app_number] => 14/229073
[patent_app_country] => US
[patent_app_date] => 2014-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 17845
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14229073
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/229073 | Marker for determining effects of anti-c-Met antibody and method of determining effects of anti-c-Met antibody using the marker | Mar 27, 2014 | Issued |
Array
(
[id] => 18203426
[patent_doc_number] => 11585815
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-21
[patent_title] => Method for diagnosis of a benign renal oncocytoma by means of VIM3
[patent_app_type] => utility
[patent_app_number] => 14/779536
[patent_app_country] => US
[patent_app_date] => 2014-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8662
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 170
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14779536
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/779536 | Method for diagnosis of a benign renal oncocytoma by means of VIM3 | Mar 24, 2014 | Issued |
Array
(
[id] => 10960398
[patent_doc_number] => 20140363426
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-11
[patent_title] => 'HETERODIMERIC PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 14/216705
[patent_app_country] => US
[patent_app_date] => 2014-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 183
[patent_figures_cnt] => 183
[patent_no_of_words] => 37659
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14216705
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/216705 | Heterodimeric proteins | Mar 16, 2014 | Issued |
Array
(
[id] => 10953360
[patent_doc_number] => 20140356381
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-04
[patent_title] => 'METHODS OF PURIFYING HETERODIMERIC PROTEINS USING IMMUNOGLOBULIN CLASS SWITCHING'
[patent_app_type] => utility
[patent_app_number] => 14/214418
[patent_app_country] => US
[patent_app_date] => 2014-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 116
[patent_figures_cnt] => 116
[patent_no_of_words] => 33703
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14214418
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/214418 | Heterodimeric proteins | Mar 13, 2014 | Issued |
Array
(
[id] => 9771171
[patent_doc_number] => 20140294835
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-02
[patent_title] => 'NOVEL HETERODIMERIC PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 14/205227
[patent_app_country] => US
[patent_app_date] => 2014-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 30742
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14205227
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/205227 | NOVEL HETERODIMERIC PROTEINS | Mar 10, 2014 | Abandoned |
Array
(
[id] => 11612596
[patent_doc_number] => 09650446
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-16
[patent_title] => 'Heterodimeric proteins'
[patent_app_type] => utility
[patent_app_number] => 14/205248
[patent_app_country] => US
[patent_app_date] => 2014-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 118
[patent_figures_cnt] => 118
[patent_no_of_words] => 40411
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 166
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14205248
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/205248 | Heterodimeric proteins | Mar 10, 2014 | Issued |
Array
(
[id] => 10679588
[patent_doc_number] => 20160025733
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-28
[patent_title] => 'METHODS OF DETECTING PROSTATE CANCER'
[patent_app_type] => utility
[patent_app_number] => 14/773599
[patent_app_country] => US
[patent_app_date] => 2014-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 27265
[patent_no_of_claims] => 81
[patent_no_of_ind_claims] => 60
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14773599
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/773599 | Methods of detecting prostate cancer | Mar 6, 2014 | Issued |
Array
(
[id] => 16743301
[patent_doc_number] => 10968276
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-06
[patent_title] => Optimized anti-CD3 variable regions
[patent_app_type] => utility
[patent_app_number] => 14/200652
[patent_app_country] => US
[patent_app_date] => 2014-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 101
[patent_figures_cnt] => 113
[patent_no_of_words] => 27931
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14200652
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/200652 | Optimized anti-CD3 variable regions | Mar 6, 2014 | Issued |
Array
(
[id] => 10483323
[patent_doc_number] => 20150368342
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-24
[patent_title] => 'CHIMERIC ANTIGEN RECEPTOR AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/766105
[patent_app_country] => US
[patent_app_date] => 2014-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 65
[patent_figures_cnt] => 65
[patent_no_of_words] => 26034
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14766105
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/766105 | CHIMERIC ANTIGEN RECEPTOR AND METHODS OF USE THEREOF | Feb 13, 2014 | Abandoned |
Array
(
[id] => 9671617
[patent_doc_number] => 20140235479
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-21
[patent_title] => 'SIGNATURES AND PCDETERMINANTS ASSOCIATED WITH PROSTATE CANCER AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/174072
[patent_app_country] => US
[patent_app_date] => 2014-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 35038
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14174072
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/174072 | SIGNATURES AND PCDETERMINANTS ASSOCIATED WITH PROSTATE CANCER AND METHODS OF USE THEREOF | Feb 5, 2014 | Abandoned |
Array
(
[id] => 10911752
[patent_doc_number] => 20140314770
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-23
[patent_title] => 'KIDNEY DISEASE TARGETS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/173082
[patent_app_country] => US
[patent_app_date] => 2014-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43019
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14173082
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/173082 | KIDNEY DISEASE TARGETS AND USES THEREOF | Feb 4, 2014 | Abandoned |
Array
(
[id] => 10642580
[patent_doc_number] => 09359437
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-06-07
[patent_title] => 'Antibodies comprising chimeric constant domains'
[patent_app_type] => utility
[patent_app_number] => 14/170166
[patent_app_country] => US
[patent_app_date] => 2014-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 15
[patent_no_of_words] => 25305
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14170166
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/170166 | Antibodies comprising chimeric constant domains | Jan 30, 2014 | Issued |
Array
(
[id] => 9537161
[patent_doc_number] => 20140161809
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-12
[patent_title] => 'DIAGNOSTIC AND THERAPEUTIC TARGET'
[patent_app_type] => utility
[patent_app_number] => 14/168907
[patent_app_country] => US
[patent_app_date] => 2014-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 8859
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14168907
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/168907 | DIAGNOSTIC AND THERAPEUTIC TARGET | Jan 29, 2014 | Abandoned |
Array
(
[id] => 9643139
[patent_doc_number] => 20140221252
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-07
[patent_title] => 'DETECTING NEOPLASM'
[patent_app_type] => utility
[patent_app_number] => 14/168552
[patent_app_country] => US
[patent_app_date] => 2014-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 15459
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14168552
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/168552 | Detecting neoplasm | Jan 29, 2014 | Issued |
Array
(
[id] => 9641944
[patent_doc_number] => 20140220056
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-07
[patent_title] => 'VACCINE COMPOSITION FOR TRANSDERMAL ADMINISTRATION'
[patent_app_type] => utility
[patent_app_number] => 14/166939
[patent_app_country] => US
[patent_app_date] => 2014-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21836
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14166939
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/166939 | VACCINE COMPOSITION FOR TRANSDERMAL ADMINISTRATION | Jan 28, 2014 | Abandoned |
Array
(
[id] => 13067639
[patent_doc_number] => 10054596
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-08-21
[patent_title] => Platelet biomarkers in cancer diagnosis
[patent_app_type] => utility
[patent_app_number] => 14/762394
[patent_app_country] => US
[patent_app_date] => 2014-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 25540
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14762394
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/762394 | Platelet biomarkers in cancer diagnosis | Jan 21, 2014 | Issued |
Array
(
[id] => 9656251
[patent_doc_number] => 20140227256
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-14
[patent_title] => 'Predictive biomarker for cancer treatment with ADCC-enhanced antibodies'
[patent_app_type] => utility
[patent_app_number] => 14/159895
[patent_app_country] => US
[patent_app_date] => 2014-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 19557
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14159895
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/159895 | Predictive biomarker for cancer treatment with ADCC-enhanced antibodies | Jan 20, 2014 | Issued |
Array
(
[id] => 9602554
[patent_doc_number] => 20140199237
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-17
[patent_title] => 'METHODS AND COMPOSITIONS FOR MODULATION OF OLFML3 MEDIATED ANGIOGENESIS'
[patent_app_type] => utility
[patent_app_number] => 14/158463
[patent_app_country] => US
[patent_app_date] => 2014-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 24739
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14158463
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/158463 | Methods and compositions for modulation of Olfml3 mediated angiogenisis | Jan 16, 2014 | Issued |
Array
(
[id] => 11737186
[patent_doc_number] => 09701759
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-07-11
[patent_title] => 'Heterodimeric proteins'
[patent_app_type] => utility
[patent_app_number] => 14/155344
[patent_app_country] => US
[patent_app_date] => 2014-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 104
[patent_figures_cnt] => 104
[patent_no_of_words] => 31051
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 193
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14155344
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/155344 | Heterodimeric proteins | Jan 13, 2014 | Issued |